Contribution of Monoamine Oxidase Inhibition to Tobacco Dependence: A Review of the Evidence (Q38617975)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Contribution of Monoamine Oxidase Inhibition to Tobacco Dependence: A Review of the Evidence	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Contribution of Monoamine Oxidase Inhibition to Tobacco Dependence: A Review of the Evidence (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

author name string

Ron C Hogg

1

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

publication date

27 October 2015

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Nicotine and Tobacco Research

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

509-523

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Monoamine oxidases and tobacco smoking

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Monoamine oxidase and cigarette smoking.

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Monoamine oxidase and tobacco dependence.

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Monoamine oxidase inactivation: from pathophysiology to therapeutics

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Monoamine oxidase: from genes to behavior

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Dopamine is a monoamine oxidase B substrate in man.

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Current place of monoamine oxidase inhibitors in the treatment of depression

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Personality traits related to monoamine oxidase activity in platelets.

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Smoking only explains part of the associations between platelet monoamine oxidase activity and personality

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Brain monoamine oxidase A inhibition in cigarette smokers

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Monoamine oxidase inhibitors allow locomotor and rewarding responses to nicotine.

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats.

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Cerebral monoamine oxidase A inhibition in tobacco smokers confirmed with PET and [11C]befloxatone

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Electrophysiological characterization of harmane-induced activation of mesolimbic dopamine neurons

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smoking

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers*

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Inhibition of monoamine oxidase B in the brains of smokers

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Low monoamine oxidase B in peripheral organs in smokers

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

A randomized controlled trial of oral selegiline plus nicotine skin patch compared with placebo plus nicotine skin patch for smoking cessation

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapy

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Selegiline transdermal system (STS) as an aid for smoking cessation

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Effects of selegiline (L-deprenyl) during smoking and short-term abstinence

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessation

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Pharmacodynamics of lazabemide, a reversible and selective inhibitor of monoamine oxidase B

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

A selective reversible monoamine oxidase B inhibitor in smoking cessation: effects on its own and in association with transdermal nicotine patch

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Transient behavioral sensitization to nicotine becomes long-lasting with monoamine oxidases inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Irreversible blockade of monoamine oxidases reveals the critical role of 5-HT transmission in locomotor response induced by nicotine in mice

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Tranylcypromine enhancement of nicotine self-administration.

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion.

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Platelet monoamine oxidase activity in subgroups of alcoholics and controls: results from the Collaborative Study on the Genetics of Alcoholism

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Platelet monoamine oxidase activity levels in subgroups of alcoholics: diagnostic, temporal, and clinical correlates

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Monoamine oxidase: associations with alcohol dependence, smoking and other measures of psychopathology.

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Relationships between effects of smoking, gender, and alcohol dependence on platelet monoamine oxidase-B: activity, affinity labeling, and protein measurements

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Different effects of smoking or use of smokeless tobacco on platelet MAO-B activity in type 1 alcohol-dependent subjects

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Platelet monoamine oxidase in healthy 9- and 15-years old children: the effect of gender, smoking and puberty

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

The deduced amino acid sequences of human platelet and frontal cortex monoamine oxidase B are identical

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Both low and high activities of platelet monoamine oxidase increase the probability of becoming a smoker

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers.

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Platelet monoamine oxidase B activity changes across 31 days of smoking abstinence.

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

The D2 dopamine receptor gene as a determinant of reward deficiency syndrome.

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Comparison of tests used to distinguish smokers from nonsmokers.

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

2-Naphthylamine, a compound found in cigarette smoke, decreases both monoamine oxidase A and B catalytic activity

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Isolation and characterization of a monoamine oxidase inhibitor from tobacco leaves

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Irreversible inhibition of monoamine oxidase by some components of cigarette smoke

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Monoamine oxidase inhibitory activity in tobacco smoke varies with tobacco type.

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Comparison of the reinforcing properties of nicotine and cigarette smoke extract in rats

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

The levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Role of acetaldehyde in tobacco smoke addiction

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Studies on the interactions of tobacco leaf and tobacco smoke constituents and monoamine oxidase

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Acetaldehyde in mainstream tobacco smoke: formation and occurrence in smoke and bioavailability in the smoker

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Intravenous self-administration of acetaldehyde in the rat as a function of schedule, food deprivation and photoperiod

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Possible involvement of acetaldehyde, norepinephrine and their tetrahydroisoquinoline derivatives in the regulation of ethanol seld-administration

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Intraventricular self-administration of acetaldehyde, but not ethanol, in naive laboratory rats

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Involvement of acetaldehyde in alcohol addiction

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

The reinforcing effects of acetaldehyde in the posterior ventral tegmental area of alcohol-preferring rats

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Quantification of the co-mutagenic beta-carbolines, norharman and harman, in cigarette smoke condensates and cooked foods

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Occurrence and partition of the beta-carboline norharman in rat organs

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

The impact of smoking and drinking on plasma levels of norharman

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Harman induces preference for ethanol in rats: is the effect specific for ethanol?

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Exposure to beta-carbolines norharman and harman

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Human monoamine oxidase enzyme inhibition by coffee and beta-carbolines norharman and harman isolated from coffee

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Relative exposure to beta-carbolines norharman and harman from foods and tobacco smoke.

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Monoamine oxidase inhibition for tobacco pharmacotherapy

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Selegiline is a mechanism-based inactivator of CYP2A6 inhibiting nicotine metabolism in humans and mice

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Placing transdermal selegiline for major depressive disorder into clinical context: number needed to treat, number needed to harm, and likelihood to be helped or harmed

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Tranylcypromine: new perspectives on an "old" drug

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Reinforcing and neural activating effects of norharmane, a non-nicotine tobacco constituent, alone and in combination with nicotine

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat.

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Nicotine self-administration in animals and humans: similarities and differences

1 reference

https://api.crossref.org/works/10.1093%2FNTR%2FNTV245

21 January 2018

Identifiers

10.1093/NTR/NTV245

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38617975&oldid=1771034545"